<DOC>
	<DOCNO>NCT02606500</DOCNO>
	<brief_summary>The aim present study determine , whether clinical efficacy 150 mcg Corifollitropin alfa normal weigh obese woman . Furthermore , investigator want determine whether oocyte retrieve normal weigh obese woman , COH use 150 mcg Corifollitropin alfa , quality molecular level .</brief_summary>
	<brief_title>Efficacy Corifollitropin Alfa Obese Women Terms Clinical Molecular Parameters IVF Success</brief_title>
	<detailed_description>The dosage Corifollitropin alfa use control ovarian hyperstimulation ( COH ) adjust accord patient 's body weight . Meaning , woman body weight â‰¤ 60 kg , single dose 100 mcg Corifollitropin alfa administer COH woman body weight &gt; 60 kg , single dose 150 microgram Corifollitropin alfa administer COH . These two protocol comparable safety efficacy follicular stimulation . On hand , knowledge clinical efficacy 150 mcg Corifollitropin alfa obese woman ( BMI &gt; 30 kg/m2 ) lacking . Cumulus cell ( CC ) surround oocyte bi-directional communication oocyte CC necessary development mature quality oocytes . It propose , analysis gene , express CC , serve objective indicator oocyte 's maturity developmental potential . Expression gene CC hyaluronan synthase 2 ( HAS2 ) , follicle-stimulating hormone receptor ( FSHR ) , versican ( VCAN ) , progesterone receptor ( PR ) , vascular endothelial growth factor C ( VEGFC ) , serine protease inhibitor E2 ( SERPINE2 ) , glutathione peroxidase ( GPX3 ) , pentraxin 3 ( PTX3 ) report correlate oocyte maturity developmental potential . The effect Corifollitropin alfa expression gene however , unknown .</detailed_description>
	<criteria>BMI &gt; 30 kg/m2 BMI 18.524.9 kg/m2 polycystic ovary syndrome , severely abnormal sperm parameter , age &gt; 38 year</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>